First ObjectiveIn this study we compare a policy of labour induction at 41 weeks with a policy of expectant management until 42 weeks, with an outpatient check for CTG monitoring and ultrasound measurement in the 42nd week, with respect to theā¦
ID
Source
Brief title
Condition
- Pregnancy, labour, delivery and postpartum conditions
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
perinatal mortality and neonatal morbidity
Adverse perinatal outcomes are defined as a 5-minute Apgar-score below 7 and/or
an arterial pH below 7.05
meconium aspiration syndrome
plexus brachialis injury
intracranial hemorrhager
NICU admission.
Secondary outcome
instrumental delivery (instrumental vaginal delivery, Caesarean section)
pain treatment (epidural, remifentanyl, pethidin)
hemorrhage and severe perineal injury (third- or fourth-degree perineal tear)
maternal experience of pain
maternal satisfaction and quality of life
client preferences for induction of labour or expectant management and the
extent to which these preferences are influenced by the attributes of obstetric
care and socio-demographic factors.
Background summary
Post-term pregnancy is associated with increased perinatal morbidity and
mortality and is considered as a high-risk stage which requires specialist
surveillance and induction of labour at some stage. However, there is
uncertainty in The Netherlands on the policy concerning the timing of induction
for post-term pregnancy, leading to practice variation and strong debates
between caregivers regarding pros and cons of labour induction for impending
post-term pregnancy. To solve this dilemma in the Netherlands we propose a
randomised trial to evaluate the effectiveness, costs and cost-effectiveness
analysis of policy of labour induction at 41 weeks versus expectant management
until 42 weeks in low risk women. We will study adverse perinatal outcome,
adverse maternal outcomes, client satisfaction, preferences and costs.
Study objective
First Objective
In this study we compare a policy of labour induction at 41 weeks with a policy
of expectant management until 42 weeks, with an outpatient check for CTG
monitoring and ultrasound measurement in the 42nd week, with respect to the
adverse perinatal outcome rate.
Secondary Objective(s):
Based on the data obtained, we will perform a cost-effectiveness analysis
incorporating instrumental delivery rates, client satisfaction and costs.
We will analyse costs of both strategies, as well as clients* preferences,
pain, anxiety and maternal satisfaction.
We will answer the following specific questions:
What is in a policy of induction of labour at 41 weeks as compared to a policy
of expectant management until 42 weeks
* Maternal satisfaction
* The instrumental delivery rate including Caesarean sections
* Need for pain relieve
* Perineal injury
* Post partum hemorrhage
* Use of health care resources
* Clients* preferences
Study design
The study is a multi-centre randomised clinical trial with a cost-effectiveness
analysis and a preference study alongside it.
Intervention
Induction of labour according to local protocol.
Study burden and risks
Participants fill out questionnaires at five occasions; at four occasions this
will take them about 15 minutes, the fifth questionnaire will take less than 5
minutes to be answered. Although formally induction of labour is only indicated
at 42 weeks gestational age, at many hospitals it is actual practice to induce
at 41 weeks GA. This study therefore compares two common treatment strategies
as a result of which it will not impose extra risk on the participants.
Meibergdreef 9
Amsterdam 1102 AZ
NL
Meibergdreef 9
Amsterdam 1102 AZ
NL
Listed location countries
Age
Inclusion criteria
- Low risk pregnancy
- Singleton pregnancy
- Gestational age between 40+5 weeks until 41+2 weeks
- Reliable dating based on first trimester ultrasound
- Stable cephalic position
- Patients of 18yrs or older
Exclusion criteria
* Ruptured Membranes
* Other obstetrical indications for secondary care
* Proteinuria .3 g/L or more
* Renal disease
* Heart disease
* Fetal abnormalities including abnormal karyotype.
* Uncertain estimates of gestational age
* No consent for immediate delivery
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL38455.018.11 |